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Thiol groups are important anti-oxidants and essential molecules protecting organism against 
the harmful effects of reactive oxygen species (ROS). The aim of our study is to evaluate 
thiol-disulphide homeostasis with a novel recent automated method in patients with localized 
prostate cancer (PC) before and six months after radical prostatectomy (RP). 18 patients with 
PC and 17 healthy control subjects were enrolled into the study. Blood samples were collected 
from the controls subjects and patients before and six months after RP. Thiol-disulphide 
homeostasis was determined using a recently developed novel method. Prostate specific 
antigen (PSA), albumin, total protein, total thiol, native thiol, disulphide and total antioxidant 
status (TAS) were measured and compared between the groups.  Native thiol, total thiol and 
TAS levels were significantly higher in the control group than the patients before RP (p 
values < 0.001). There was a non-significant increase in the native thiol, total thiol and TAS 
levels in the patients six months after RP in comparison to the levels before RP (p values 0.3, 
0.3 and 0.09 respectively). We found a significant negative correlation between PSA and thiol 
levels. Our study demonstrated that the decreased thiol and TAS levels weakened anti-oxidant 
defence mechanism in the patients with PC as indicated. Increased oxidative stress in prostate 
cancer patients may cause metabolic disturbance and have a role in the aetiopathogenesis of 
prostate cancer. 












Prostate cancer (PC) is the second most common cancer and the second most common cause 
of death in male cancer patients [1,2]. Radical prostatectomy (RP) is the main treatment 
modality for patients with localized (non-metastatic) PC [3]. Previous studies demonstrated 
that ageing, genetic predisposition, androgen hormone levels, dietary factors, inflammation 
and oxidative stress play crucial role in the initiation and development of PC. Oxidative stress 
in the development of PC has been under intensive research [4]. 
Oxidative stress due to the excessive production of reactive oxygen species (ROS) causes 
damages to DNA, protein and lipids. Oxidative protein damage causes irreversible 
modifications in serum and tissue proteins. The structure and activity of oxidized proteins and 
biomolecules change markedly in comparison to their native forms. Oxidative modification of 
DNA and proteins may affect a variety of cellular functions, and cause cell damage and death 
or mutations and carcinogenesis [5,6]. Thiols are essential and potent anti-oxidant molecules 
containing a functional sulfhydryl group protecting organism against the harmful effects of 
oxidative stress damage. Thiol groups in cysteine, homocysteine, glutathione, albumin and 
other proteins, constituents of the antioxidant defence mechanism, are oxidized by ROS, 
giving rise to reversible disulphide bonds. The disulphide bonds can be reversibly reduced to 
thiol groups by a number of antioxidants [7]; in this way the thiol/disulphide homeostasis is 
maintained. Dynamic thiol-disulphide homeostasis has a crucial role in redox states such as 
antioxidant defence, oxidation of proteins, apoptosis, activity of enzymes, and cellular signal 
transduction mechanism. Thiol-disulphide homeostasis has been measured since 1979 only in 
one direction, but the novel method recently developed by Erel and Neselioglu allows the 
levels of both variables to be measured separately, as well as jointly [8]. 
In our study, we measured plasma native thiol, total thiol, and disulphide levels, then 
calculated the ratios of disulphide/native thiol, disulphide/total thiol, and native thiol/total 
thiol in the plasma of prostate cancer patients before and six months after radical 
prostatectomy operation using a novel, automated method in order to determine the level of 
dynamic thiol/ disulphide homeostasis. According to the results of our literature search, 
thiol/disulphide homeostasis has not been studied and measured using such a novel method in 
patients with prostate cancer, thus our study provides original data on this important issue.   
 




The study was conducted in accordance with the Declaration of Helsinki, and approved by the 
local ethical committee; written informed consent was received from the patients and control 
subjects before being included into the study. The patients and control cohorts were recruited 
at the Urology Department, Medical Faculty, Akdeniz University. 
18 patients newly diagnosed with localized (non-metastatic) prostate cancer and 17 
healthy, age and body mass index (BMI)-matched male control subjects having normal PSA 
levels and no prostate disease were enrolled into the study. Subjects who had a history of liver 
diseases, chronic ischemic diseases, systemic inflammatory diseases or using antioxidant 




Fasting morning venous blood samples were collected from the patients before and six 










separating tubes. After centrifugation, separated plasma and serum samples were frozen at -
80°C until analysis. Samples with significant absorptions in the red region of the visible 
spectrum, which equates to extracellular haemoglobin levels of greater than approximately 0.3 
g/l, were excluded from the study analyses. Thiol-disulphide homeostasis was determined 
with a novel method described previously [8]. Albumin was measured by the bromocresol 
green method; total protein by enzymatic colorimetric method; prostate specific antigen 
(PSA) by electrochemiluminescense. Total antioxidant status was determined using an 




Statistical analysis was performed using SPSS Statistics (SPSS Inc. Chicago, IL, USA). 
Quantitative data were given as mean ± SD or medians (interquartile ranges, IQR). Normal 
distribution and differences between variances were determined using Kolmogorov-Smirnov 
and Levene tests, respectively. For comparisons between two groups, Student’s t test and 
Mann Whitney U test were used as appropriate. For subgroup analyses, Kruskal-Wallis test 
was used to determine significant differences. Mann-Whitney U test was used to determine 
differences among groups if a significant difference was found in Kruskal-Wallis test. 





Laboratory findings of the patients and control group including disulphide/native thiol, 
disulphide/total thiol and native thiol/total thiol ratios are shown in Table 1. There was no 
significant difference in terms of age (65.5 ± 5.1 year vs 66.7 ± 5.2 year, p=0.5) and body 
mass index (26.81 ± 2.32 kg/m² vs 26.48 ± 2.18 kg/m², p=0.6) between patients and control 
subjects. Native thiol and total thiol levels in all of the groups are shown as whiskers graphs 
in Figure 1 and 2. Native thiols, total thiols, disulphide and TAS levels were significantly 
higher in the control group compared to the patient group before RP (p values <0.001, 0.0001, 
0.02 and 0.0001, respectively). As expected, PSA levels were higher in the patients before RP 
compared to the controls and patients after RP (both p<0.0001). There was a significant 
negative correlation between the PSA levels and native and total thiol levels in the control 
subjects and patient group before RP (p=0.01, r= -0.4 and p=0.001, r= -0.51 respectively).  
 
Patients six months after RP in comparison to the patients before the operation had higher 
native thiol levels (364.3 ± 46.88 µmol/L vs 350.7 ± 46.35 µmol/L, p= 0.3) and higher total 
thiol levels (392 ± 44.2 vs 378.8 ± 46.52, p= 0.3), but these increases were not statistically 
significant  (p= 0.3, p= 0.3, respectively).  Similarly, the decreases in total protein and 
albumin levels (p=0.09 and p=0.1, respectively) and the increase of TAS level (1.22 ± 0.22 
mmol Trolox Equivalent/L vs 1.09 ± 0.21 mmol Trolox Equivalent/L, p=0.09) were not 
significantly different in patient group after RP compared to patients before RP. Native thiols, 
total thiols, disulphide, TAS and albumin levels were significantly higher in the control group 
compared to the patients after RP (p values 0.002, 0.0004, 0.007, 0.02 and 0.007, 
respectively). No other significant differences in the measured parameters were found among 











Previous studies have shown that impaired oxidant-antioxidant status in the prostate plays a 
role in the initiation and progression of PC [10].  The relation between oxidative stress and 
prostate diseases such as benign prostate hyperplasia (BPH), prostate inflammation, and 
prostate cancer has been investigated in various studies [6,11].  No study has been performed 
so far to elucidate the dynamic of thiol/disulphide levels in blood of PC patients. Glutathione 
(GSH) level was found lower in PC patients compared with the controls [12]. Only a small 
thiol fraction is found among low molecular weight compounds, such as cysteine (Cys), 
cysteinylglycine, GSH, homocysteine and γ-glutamylcysteine; the main part is found in 
albumin and other plasma proteins [13,14].  
 
The novel automated measurement method used in our study provided us with an opportunity 
to measure serum/plasma total thiol, native thiol, and disulphide levels. Recent studies have 
demonstrated an imbalance in thiol-disulphide homeostasis status involved in the 
aetiopathogenesis of diabetes mellitus [15], cardiovascular disease [16], cancer [17], 
rheumatoid arthritis [18], chronic kidney disease [19], Parkinson's disease [20] and liver 
disease [21]. Therefore, the determination of dynamic thiol disulphide homeostasis can 
provide valuable information in physiological and pathological biochemical processes. In 
previous studies Erel et al. showed that plasma disulphide levels were higher in smokers and 
in patients with, diabetes, obesity, and pneumonia; while plasma disulphide resulted lower in 
patients with proliferative diseases such as multiple myeloma, urinary bladder cancer, colon 
cancer and renal cancer. Aggressively growing tumours showed the lowest disulphide levels, 
while slowly growing ones showed subnormal values [8].  
 
It was also previously shown that the increase of disulphide/native thiol ratio is positively 
correlated with age [22]. This show us that oxidative stress may increase with age [23] and 
disulphide/thiol homeostasis may shift towards disulphide. Further studies have confirmed the 
positive correlation between oxidative stress and age; while a negative correlation between 
native thiol level and both age and BMI has been determined [13]. As stated in the Study 
Subjects section, the controls and study group were matched for age and BMI, hence the correlation 
of thiol levels with BMI and age could not be carried out. Furthermore, a negative correlation with 
BMI has been shown for TAC levels [24]. In order to avoid the effect of age and BMI on 
oxidative stress and thiol levels, we enrolled age- and BMI-matched patients with localized 
(nonmetastatic) prostate cancer and healthy control subjects into our study.  
 
While there are numerous studies reporting increased oxidative stress in PC patients, only a 
limited number of studies have demonstrated the level of antioxidant capacities. Oxidative 
stress biomarkers, such as thiobarbituric acid reactive substances, total oxidative status, 
malondialdehyde, plasma nitrite/nitrate levels, lipid peroxide activities were reported to be 
elevated in PC patients compared to the healthy controls [25,26]. In addition, decreased 
antioxidant enzymes such as catalase, manganese containing superoxide dismutase (MnSOD), 
copper and zinc containing superoxide dismutase (Cu,ZnSOD) [27], glutathione peroxidase 
(GPX) and impairment of oxidative stress/antioxidant status have been  reported in PC 
patients [2]. Aryal et al. found decreased levels of antioxidant vitamins such as α-tocopherol 
and ascorbate levels in benign prostate hyperplasia patients [28]. Other studies reported a 
positive correlation between oxidative stress and progression to PC and anti-oxidants like 
vitamin E and selenium decreased risks for PC [29]. 
 
It is known that thiol groups have a crucial role in ROS detoxification and a thiol decrease 










homeostasis and thiol oxidation have regulatory critical roles in protection against oxidative 
stress, detoxification, regulation of enzymes and essential cellular pathways such as signal 
transduction, pro-apoptotic, anti-apoptotic signalling [30]. As stressed above, there is no 
information available regarding native thiol and disulphide levels in PC patients. Therefore 
we performed our study to fill this gap and provide data on this important point, examining 
thiol and disulphide levels in PC patients just before and 6 months after radical prostatectomy.  
 
A significant decrease in total thiol, native thiol, disulphide and TAS levels was found in PC 
patients before RP compared with the control group. The reason for the low disulphide levels 
in patients group before RP (p=0.02) lies in the dramatic native thiol loss (p<0.001) and the 
deteriorating capacity to resist oxidant stress (p<0.0001), when compared with control 
subjects.  As a result, an impaired thiol/disulphide balance occurs in these patients before RP.  
 
Native thiols, total thiols and TAC levels increased, while disulphide levels decreased, 
however in a non-significant manner six months after RP surgery, when compared to the 
preoperatory levels. These findings indicate that thiol/disulphide homeostasis begins to shift 
towards thiols following the operation; hence thiol levels and total antioxidant capacity 
increases following RP. Although the levels of native thiol and TAS increased in the patients 
after RP, they were still significantly lower than native thiols and TAS levels when compared 
with the control group (p=0.002, 0.02, respectively).  One of the limitations of our study is the 
short follow-up time (six months) after RP. The observed increasing trend in native thiol and 
TAS, however non-significant, is expected to be significantly higher in a longer follow-up 
time.   
 
PSA is the most common used biomarker for PC diagnosis, and at the same time PSA, tumour 
volume and Gleason score are the main prognostic factors related to the severity of PC.  Kato 
et al demonstrated a direct correlation between PSA levels and tumour volume in patients 
with localized PC [31]. Thus, PSA levels are of crucial importance for estimating tumour 
volume at the diagnosis. In our study, a significant negative correlation between PSA levels 
and both, native thiols and total thiols was found comparing the control group with patient 
before RP (p=0.01, r= -0.4 and p=0.001, r= -0.51 respectively). Thus, decreased thiol levels 
might be considered as a marker to indicate prostate tissue tumour volume and disease 
severity.  
 
In a recent study, researchers compared glutathione to glutathione disulphide ratios in 
malignant and non-malignant human prostate cell lines. The results demonstrated that the 
more aggressive phenotype of prostate cancer cells shows adaptation to increased oxidative 
stress via up-regulation of glutathione turnover [32]. To the extent of our knowledge, there is 
no literature evaluating the relationship between thiol and PSA levels. We can hypothesize 
that decreased thiol levels associated to increased tissue damage result in PSA increase. We 
are aware that the small number of patients recruited in our study may pose a limit to our 
interpretation; further studies assessing thiol and PSA levels are needed to fully clarify the 
relation of decreased thiol levels with increased PSA levels as a prognostic marker in this 
relevant health problem. 
 
Conclusion  
PC patients have a decreased ability to cope with oxidative stress, as demonstrated by the 
decrease of TAS and native thiol levels. If the decrease in total and native thiol levels is the 
cause or result of prostate cancer development in the patients merit further investigations. We 










TAS is directly related to an increased oxidative damage in prostate tissue, playing an 
important role in progression to PC.  
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Table 1: Laboratory findings of the control group and patient groups before and six months 
after RP. PSA levels were expressed as mean (median), other data were expressed as mean 
±SD.  P < 0.05 was considered significant for statistical analyses and only significant statistics 
were shown in the table. a: Control group compared to the patient group before RP,  b: 
Control group compared to the patient group after RP, c: Patient group before RP compared to 





Figure 1. Box-and-whisker plot of native thiol levels in the control group (Median: 436.3 
µmol/L),patient group before RP (Median: 338.3 µmol/L) and patient group after RP 
(Median: 367.5 µmol/L) groups (Whiskers: 10 and 90 percentile). The middle lines, upper and 
lower margin of boxes represent medians.   
 
 
Figure 2. Box-and-whisker plot of total thiol levels in the control group (Median: 467.2 
µmol/L), patient group before RP (Median: 363.1 µmol/L) and patient group after RP 
(Median: 393.2 µmol/L)   (Whiskers: 10 and 90 percentile). The middle lines, upper and 
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PSA (ng/mL) 0.64 ± 0.58 6.04 ± 3.92 0.005 ± 0.017 < 0.0001 a,b,c 
Total protein (g/dl) 7.6 ± 0.4 8 ± 0.5 7.7 ± 0.4  
Albumin (g/dl) 4.86 ± 0.2 4.74 ± 0.3 4.59 ± 0.2 0.007 b 
TAS (mmol Trolox 
Equivalent/L) 
 
1.36 ± 0.1 
 
1.09 ± 0.21 1.22 ± 0.22 
< 0.0001 a, 
0.02 b 
Native thiol (µmol/L) 419.8 ± 54.87 350.7 ± 46.35 364.3 ± 46.88 
< 0.001 a, 
0.002 b 
Total thiol (µmol/L) 462.3 ± 61.52 378.8 ± 46.52 392 ± 44.20 
< 0.0001 a, 
0.0004 b 





5.06 ± 1.34 4.16 ± 3.36 3.98 ± 2.81  
Disulphide/total thiol 
(%) 
4.57 ± 1.1 3.67 ± 2.7 3.57 ± 2.2  
Native thiol/total 
thiol (%) 
90.8 ± 2.2 92.6 ± 5.5 92.8 ± 4.5  
 
PSA: Prostate spesific antigen; TAS: Total antioxidant status. 
PSA levels were expressed as mean (median) and other datas were expressed as mean ±SD.   
P < 0.05 was considered significant for statistical analyses and only significant statistics were shown in the table. 
a: Control group compared to the patient group before RP,  
b: Control group compared to the patient group after RP,  
c: Patient group before RP compared to the patient group after RP. 
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